From strategy to submission: How your CRO should create value beyond execution
Clinical research organizations (CROs) have transformed into major strategic partners for biotechnology and pharmaceutical companies. From protocol design to commercialization planning, their integrated support services and global reach add substantial value across the drug development lifecycle - particularly for small and mid-sized biopharma
